COVID-19 pandemic: The role of community pharmacists in chronic kidney disease management supportive care.
Res Social Adm Pharm
; 17(1): 1925-1928, 2021 01.
Article
in English
| MEDLINE | ID: covidwho-635226
ABSTRACT
The COVID-19 pandemic is putting enormous pressure on healthcare systems worldwide and various countries are struggling to flatten the curve to prevent their healthcare system from becoming overwhelmed. Studies have shown that people with chronic kidney disease (CKD) are at increased risk of COVID-19 infection and mortality. However, the interruption of routine care and support due to the current challenges with healthcare providers, facilities, and essential medicines due to this pandemic is adversely affecting people with CKD. This is because poor management of this disease leads to negative health outcomes. In order to maintain good health, this vulnerable group of patients rely heavily on the extended role of the community pharmacists in chronic disease management. This paper highlights the extended role of the community pharmacists in CKD management supportive care during the COVID-19 pandemic.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pharmacists
/
Community Pharmacy Services
/
Renal Insufficiency, Chronic
/
COVID-19
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
Res Social Adm Pharm
Journal subject:
Pharmacy
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS